Page last updated: 2024-09-05

regadenoson and dacarbazine

regadenoson has been researched along with dacarbazine in 3 studies

Compound Research Comparison

Studies (regadenoson)	Trials (regadenoson)	Recent Studies (post-2010) (regadenoson)	Studies (dacarbazine)	Trials (dacarbazine)	Recent Studies (post-2010) (dacarbazine)
321	53	264	7,556	1,463	3,429

Protein Interaction Comparison

Protein	Taxonomy	regadenoson (IC50)	dacarbazine (IC50)
Matrix metalloproteinase-9	Homo sapiens (human)		0.556

Research

Studies (3)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	3 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K	1
Anders, NM; Brem, H; Grossman, SA; Jackson, S; Liu, A; Mangraviti, A; Rudek, MA; Sankey, EW; Tyler, B; Wanjiku, TM	1
Anders, NM; Figg, WD; George, RT; Gilbert, M; Grossman, SA; Harfi, TT; Jackson, S; McAreavey, D; Nduom, EK; Peer, C; Rudek, MA; Weingart, J; Ye, X	1

Reviews

1 review(s) available for regadenoson and dacarbazine

Article	Year
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans. Drug discovery today, 2016, Volume: 21, Issue:4 Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk	2016

Trials

1 trial(s) available for regadenoson and dacarbazine

Article	Year
The effect of an adenosine A Fluids and barriers of the CNS, 2018, Jan-15, Volume: 15, Issue:1 Topics: Adenosine A2 Receptor Agonists; Administration, Intravenous; Administration, Oral; Adult; Aged; Antineoplastic Agents, Alkylating; Brain; Brain Neoplasms; Dacarbazine; Feasibility Studies; Female; Glioblastoma; Humans; Male; Middle Aged; Neoplasm Recurrence, Local; Purines; Pyrazoles; Receptor, Adenosine A2A; Temozolomide	2018

Article

Year

The effect of an adenosine A

Fluids and barriers of the CNS, 2018, Jan-15, Volume: 15, Issue:1

Topics: Adenosine A2 Receptor Agonists; Administration, Intravenous; Administration, Oral; Adult; Aged; Antineoplastic Agents, Alkylating; Brain; Brain Neoplasms; Dacarbazine; Feasibility Studies; Female; Glioblastoma; Humans; Male; Middle Aged; Neoplasm Recurrence, Local; Purines; Pyrazoles; Receptor, Adenosine A2A; Temozolomide

2018

Other Studies

1 other study(ies) available for regadenoson and dacarbazine

Article	Year
The effect of regadenoson-induced transient disruption of the blood-brain barrier on temozolomide delivery to normal rat brain. Journal of neuro-oncology, 2016, Volume: 126, Issue:3 Topics: Animals; Antineoplastic Agents, Alkylating; Blood-Brain Barrier; Brain; Dacarbazine; Drug Delivery Systems; Female; Purines; Pyrazoles; Rats; Rats, Inbred F344; Tandem Mass Spectrometry; Temozolomide; Tissue Distribution	2016

Article

Year

The effect of regadenoson-induced transient disruption of the blood-brain barrier on temozolomide delivery to normal rat brain.

Journal of neuro-oncology, 2016, Volume: 126, Issue:3

Topics: Animals; Antineoplastic Agents, Alkylating; Blood-Brain Barrier; Brain; Dacarbazine; Drug Delivery Systems; Female; Purines; Pyrazoles; Rats; Rats, Inbred F344; Tandem Mass Spectrometry; Temozolomide; Tissue Distribution

2016